181 related articles for article (PubMed ID: 19157620)
1. Alteration of protein glycosylation in liver diseases.
Blomme B; Van Steenkiste C; Callewaert N; Van Vlierberghe H
J Hepatol; 2009 Mar; 50(3):592-603. PubMed ID: 19157620
[TBL] [Abstract][Full Text] [Related]
2. [The alteration of proteins glycosylation in liver diseases].
Chrostek L; Cylwik B
Pol Merkur Lekarski; 2011 Jul; 31(181):60-4. PubMed ID: 21870713
[TBL] [Abstract][Full Text] [Related]
3. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics.
Ventura P; Rosa MC; Abbati G; Marchini S; Grandone E; Vergura P; Tremosini S; Zeneroli ML
Liver Int; 2005 Feb; 25(1):49-56. PubMed ID: 15698398
[TBL] [Abstract][Full Text] [Related]
5. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins.
Takahashi M; Kuroki Y; Ohtsubo K; Taniguchi N
Carbohydr Res; 2009 Aug; 344(12):1387-90. PubMed ID: 19508951
[TBL] [Abstract][Full Text] [Related]
6. Molecular forms of glucose-6-phosphate dehydrogenase in liver diseases.
Watanabe A; Taketa K; Kosaka K
Acta Med Okayama; 1973 Apr; 27(1):15-26. PubMed ID: 4358254
[No Abstract] [Full Text] [Related]
7. [Importance of enzyme studies in chronic liver diseases. II].
Dán S; Ladányi J; Pongrácz E; Antal L; Dévényi I
Acta Hepatosplenol; 1966; 13(6):349-56. PubMed ID: 5994990
[No Abstract] [Full Text] [Related]
8. [Serum cathepsin activity in chronic liver diseases].
Kucharz EJ; Kucharz M
Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
[TBL] [Abstract][Full Text] [Related]
9. Abnormal glycoproteins and glycosyltransferases in human hepatoma.
Waxman S; Liu CK; Schmied R
Ann N Y Acad Sci; 1980; 349():411-2. PubMed ID: 6261637
[No Abstract] [Full Text] [Related]
10. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
Noda K; Miyoshi E; Uozumi N; Yanagidani S; Ikeda Y; Gao C; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Hayashi N; Hori M; Taniguchi N
Hepatology; 1998 Oct; 28(4):944-52. PubMed ID: 9755230
[TBL] [Abstract][Full Text] [Related]
12. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
13. Studies on the in-vitro biotransformation in patients with liver diseases.
Truckenbrodt J; Kraul H; Machnik G; Volland R; Hoffmann A
Gastroenterol J; 1989; 49(3):126-8. PubMed ID: 2629781
[TBL] [Abstract][Full Text] [Related]
14. Altered serum N-glycomics in chronic hepatitis B patients.
Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
[TBL] [Abstract][Full Text] [Related]
15. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.
Vanhooren V; Liu XE; Franceschi C; Gao CF; Libert C; Contreras R; Chen C
Mech Ageing Dev; 2009; 130(1-2):92-7. PubMed ID: 19070631
[TBL] [Abstract][Full Text] [Related]
16. Altered plasma and tissue fucosyltransferase activities in hepatocellular carcinoma.
Du MQ; Hutchinson WL; Johnson PJ; Williams R
Biochem Soc Trans; 1990 Jun; 18(3):489. PubMed ID: 2165000
[No Abstract] [Full Text] [Related]
17. [The diagnostic value of glutamic acid dehydrogenase].
Rettenbacher-Däubner H; Rieder H; Sburny I
Acta Hepatosplenol; 1967; 14(4):209-21. PubMed ID: 4297959
[No Abstract] [Full Text] [Related]
18. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
Itoh N; Sakaue S; Nakagawa H; Kurogochi M; Ohira H; Deguchi K; Nishimura S; Nishimura M
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1069-77. PubMed ID: 17666489
[TBL] [Abstract][Full Text] [Related]
19. Collagen peptidase in chronic liver disorders.
Kucharz E; Droźdź M; Obuchowicz E
Z Med Lab Diagn; 1981; 22(6):307-13. PubMed ID: 6282003
[No Abstract] [Full Text] [Related]
20. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis.
Hutchinson WL; Du MQ; Johnson PJ; Williams R
Hepatology; 1991 Apr; 13(4):683-8. PubMed ID: 1849114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
